Join
Live feed
·
INSIDERFilingvia Quantisnow
Turn Therapeutics Inc. logo

Officer Chaudhary Zuraiz bought $9,050 worth of shares (2,500 units at $3.62), increasing direct ownership by 50% to 7,550 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TTRX· Turn Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TTRX (Turn Therapeutics Inc.) and more on Quantisnow.